Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Citicoline Concentration in Human Vitreous After Topical Administration
NCT04003090Completed
- Sponsor
- Istituto di Ricerca in Neuroftalmologia
- Start
- Mar 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of citicoline in epiretinal membrane (ERM) (2 arms), sponsored by Istituto di Ricerca in Neuroftalmologia. Primary endpoint: Citicoline and metabolites concentration in human vitreous at 14 days. Started Mar 2018; status: completed.
02
Drugs
citicoline
03
Conditions
epiretinal membrane (ERM)
Beyond the preview
Go deeper on NCT04003090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003090.